Yatharth Hospital Intrinsic Value
YATHARTH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹205.44 | ₹164.35 - ₹246.53 | -68.2% | EPS: ₹17.12, Sector P/E: 12x |
| Book Value Method | asset | ₹170.52 | ₹153.47 - ₹187.57 | -73.6% | Book Value/Share: ₹170.52, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹193.77 | ₹174.39 - ₹213.15 | -70.0% | Revenue/Share: ₹120.42, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹258.36 | ₹232.52 - ₹284.20 | -60.0% | EBITDA: ₹296.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹258.36 | ₹206.69 - ₹310.03 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹193.77 | ₹174.39 - ₹213.15 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹193.77 | ₹174.39 - ₹213.15 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹322.95 | ₹290.65 - ₹355.25 | -50.0% | ROE: 10.0%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹256.29 | ₹230.66 - ₹281.92 | -60.3% | EPS: ₹17.12, BVPS: ₹170.52 |
Want to compare with current market value? Check YATHARTH share price latest .
Valuation Comparison Chart
YATHARTH Intrinsic Value Analysis
What is the intrinsic value of YATHARTH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Yatharth Hospital (YATHARTH) is ₹205.44 (median value). With the current market price of ₹645.90, this represents a -68.2% variance from our estimated fair value.
The valuation range spans from ₹170.52 to ₹322.95, indicating ₹170.52 - ₹322.95.
Is YATHARTH undervalued or overvalued?
Based on our multi-method analysis, Yatharth Hospital (YATHARTH) appears to be trading above calculated value by approximately 68.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 85.60 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.06 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 10.0% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 23.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Yatharth Hospital
Additional stock information and data for YATHARTH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹150 Cr | ₹-60 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-3 Cr | ₹-116 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹64 Cr | ₹54 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹60 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹44 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |